Furthermore, emerging evidence identifies the combined biomarkers of elevated serum IL-6 levels and reduced BDNF concentrations as reliable predictors of depression severity (55), laying the foundation for multidimensional biomarker assessment systems. The gene discussed is IL6; the disease is depressive disorder.